Symbol="EVLO"
AssetType="Common Stock"
Name="Evelo Biosciences Inc"
Description="Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. The company is headquartered in Cambridge, Massachusetts."
CIK="1694665"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="620 MEMORIAL DRIVE, SUITE 200 WEST, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="118849000"
EBITDA="-91120000"
PERatio="None"
PEGRatio="None"
BookValue="-8.24"
DividendPerShare="0"
DividendYield="0"
EPS="-17.46"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.876"
ReturnOnEquityTTM="-62.33"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-17.46"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="6.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="22.31"
EVToRevenue="-"
EVToEBITDA="-1.714"
Beta="1.573"
num_52WeekHigh="52.9"
num_52WeekLow="1.586"
num_50DayMovingAverage="6.72"
num_200DayMovingAverage="14.2"
SharesOutstanding="18835100"
DividendDate="None"
ExDividendDate="None"
symbol="EVLO"
open="5.50"
high="6.60"
low="5.50"
price="6.31"
volume="258955.00"
latest_trading_day="2023-08-25"
previous_close="5.48"
change="0.83"
change_percent="15.1460%"
aroon_positive_momentum_days="28"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="28"
Volume_recent_avg="7218089"
Change_recent_avg="0.06"
Delta_recent_avg="0.65"
Variance_recent_avg="0.33"
Change_ratio_recent_avg="-3.64"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="28"
Aroon_momentum_negative="72"
image_negative_thumbnail_id_1="153"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0023.jpeg"
image_negative_thumbnail_id_2="135"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0041.jpeg"
image_neutral_thumbnail_id_1="538"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_neutral_thumbnail_id_2="574"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_positive_thumbnail_id_1="619"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0089.jpeg"
image_positive_thumbnail_id_2="691"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0017.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
